Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,285
datasets available to search
ShareScore release 0.9.0
Dataset results
2,285 results for “T-cells”
Peripheral Helper T-cells in Common Variable ImmunoDeficiency
ClinicalTrials.gov study NCT07255157. IPD Sharing: NO. Countries: 1. Publications: 0.
Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV
ClinicalTrials.gov study NCT01535885. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol
ClinicalTrials.gov study NCT05648019. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas
ClinicalTrials.gov study NCT02223208. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
ClinicalTrials.gov study NCT06934382. IPD Sharing: NO. Countries: 1. Publications: 0.
BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM)
ClinicalTrials.gov study NCT07009899. IPD Sharing: NO. Countries: 1. Publications: 0.
T-cell Diversity Following Intranasal and Intramuscular Vaccines
ClinicalTrials.gov study NCT02557802. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymph
ClinicalTrials.gov study NCT00004907. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.
ClinicalTrials.gov study NCT05821192. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma
ClinicalTrials.gov study NCT06909877. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma Patients
ClinicalTrials.gov study NCT01776411. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin.
ClinicalTrials.gov study NCT00071071. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vaccine Enriched, Autologous, Activated T-Cells Directed to Tumor in Patients With Relapsed/Refractory Melanoma
ClinicalTrials.gov study NCT02482532. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide, Vorinostat and Dexamethasone in Relapsed Patients With Peripheral T-Cell Non-Hodgkin's Lymphoma (PTCL)
ClinicalTrials.gov study NCT00972842. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
ClinicalTrials.gov study NCT04414046. IPD Sharing: NO. Countries: 1. Publications: 0.
Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases
ClinicalTrials.gov study NCT06939166. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous Nephropathy
ClinicalTrials.gov study NCT07266181. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tumorspecific T-cell Immunity in Bladder Cancer as Prognostic Marker
ClinicalTrials.gov study NCT01198808. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Genetically Engineered Cells (MUC1-Activated T-Cells) for the Treatment of MUC1 Positive Recurrent or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05411497. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Engineered T-Cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors
ClinicalTrials.gov study NCT07123493. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.